Introduction
Cells sense environmental signals via distinct surface receptors that bind ligands such as growth factors, extracellular matrix (ECM) proteins or cell surface adhesion molecules on adjacent cells. These receptors in turn activate signalling pathways, which communicate the state of the environment to the cell nucleus. Regarding cell growth, these signals can be either positive or negative; for example, activation of receptor tyrosine kinases and integrin-dependent cell-matrix adhesions stimulate cell survival and proliferation (Chen et al., 1997) , whereas cell-to-cell adhesion through cadherins inhibits cell growth at saturating densities in a process termed contact inhibition (Nelson and Daniel, 2002) . The complex signalling pathways involved in both positive and negative growth signals rely, at least in part, upon phosphorylation at specific tyrosine residues.
The signal transducer and activator of transcription (STAT) proteins were initially discovered as key mediators of cytokine signalling Levy and Darnell, 2002) . Later studies demonstrated that the STAT proteins are also activated by receptor tyrosine kinases such as the receptors for the epidermal growth factor or platelet-derived growth factor (EGFR and PDGFR, respectively), or the nonreceptor tyrosine kinase Src (Vignais et al., 1996; Bromberg et al., 1998; Turkson et al., 1998; Vignais and Gilman, 1999; Wang et al., 2000) . STATs are invariably latent in the cytoplasm, and subsequent to binding to an activated receptor through their SH2 domains, STATs become activated through phosphorylation by the receptor itself or by the associated Janus kinase (JAK) or c-Src tyrosine kinases. Phosphorylation of a single critical tyrosine residue activates STATs by stabilizing the association of two STAT monomers through reciprocal SH2-ptyr interactions to form a dimer that migrates to the nucleus and binds specific DNA sites to initiate transcription from a number of genes. Seven distinct STAT proteins have so far been identified in mammalian cells and they are known to form heterodimers (e.g. Stat1:Stat3), resulting in crosstalk among various Stat pathways . Signalling through Stat3 is determined by a key phosphorylation at tyr705. Later work indicated that inappropriate activation of specific STATs such as Stat3 occurs with high frequency in a number of human cancers, while constitutively high Stat3 activity is required for the growth and survival of many tumor-derived cultured cells (Catlett-Falcone et al., 1999a; Coffer et al., 2000; Song and Grandis, 2000; Turkson and Jove, 2000; Garcia et al., 2001) . Moreover, a constitutively activated Stat3 mutant (Stat3C) alone is sufficient to induce cell transformation and tumor formation in nude mice (Bromberg et al., 1999) , providing genetic evidence for the growthpromoting potential of Stat3. Nevertheless, an increase in Stat3 activity has also been noted in cells entering the growth arrest phase, which precedes the differentiation of keratinocytes (Hauser et al., 1998) or adipocytes (Stephens et al., 1996; Balhoff and Stephens, 1998; Deng et al., 2000) .
We previously demonstrated a high frequency of elevated Stat3 activity in human breast carcinoma lines (Garcia et al., 1997 (Garcia et al., , 2001 . Given that confluence alters tyrosine phosphorylation (Batt and Roberts, 1998; Xu and Zhao, 2001) , which is key to activation of the STAT proteins, we studied the effects of cell density upon Stat3 activity. In agreement with previous reports, our results showed constitutively high levels of Stat3 activity in breast carcinoma lines, in contrast to normal breast epithelial cells. Unexpectedly however, our results also revealed a dramatic increase in Stat3 phosphorylation at tyr705 (Stat3-ptyr705) and consequently Stat3 activity with cell density in normal cells, which peaked at approximately 1-2 days postconfluence and gradually declined as cell death ensued. This confluence-dependent activation was eliminated if cell-to-cell interactions were interrupted through calcium chelation. Further investigation showed that this event was dependent on JAK activity but was refractory to inhibition of Fer, IGF1-R or Src family kinases. In breast carcinoma lines that are known to harbor activated Src on the other hand, the high constitutive Stat3 activity was reduced by pharmacological inhibitors of Src as well as JAK. These results suggest the existence of two distinct pathways for Stat3 activation in transformed cells. More importantly, despite the association of Stat3 with cell proliferation, our results reveal an increased Stat3 activity in normal cells with cell-to-cell contact, under growth arrest conditions. Therefore, it appears that Stat3 may be situated at a molecular junction which can allow cell proliferation but also growth arrest, depending on the state of the cell.
Results

Cell density upregulates stat3 activity in human breast carcinoma lines
We previously demonstrated a high frequency of elevated Stat3 activity in human breast carcinoma lines such as MDA-MB-468, MDA-MB-231 and MDA-MB-435, while MDA-MB-453 displayed lower levels (Garcia et al., 1997 (Garcia et al., , 2001 . Given that confluence of cultured adherent cells modulates protein-tyrosine phosphorylation, we examined the phosphorylation status of Stat3, tyrosine-705 in these lines as a function of cell density. Cells were plated in plastic Petri dishes. When B50-80% confluent, and over several days thereafter cell extracts were prepared and Western blots probed with an antibody specific for the tyr-705 phosphorylated form of Stat3 (see Materials and methods). As shown in Figure 1A -D (top panels), there was a dramatic increase in Stat3-tyr705 phosphorylation with density in all lines tested, which peaked at 1-2 days postconfluence (lane 1 vs 4). The levels obtained at that time in MDA-MB-453 cells were approximately a third of the levels observed in MDA-MB-468 cells that were previously shown to depend on Stat3 activity for growth and survival (Garcia et al., 2001) . As a loading control, blots were probed with an antibody to the abundant heat shock protein, Hsp90 ( Figure 1A -D, bottom panels; see Materials and methods).
To reduce the variability that might be caused by nutrient depletion in postconfluent cultures, in a separate experiment the medium was changed every 24 h and the cells processed as above. In addition, to better control the degree of cell-to-cell contact, we repeated the experiment by plating different numbers of cells (0.6 Â 10 6 , 0.8 Â 10 6 , 1.1 Â 10 6 , 1.5 Â 10 6 or 1.8 Â 10 6 per 3 cm Petri dish, respectively), so that they would reach the same densities as above within 24 h. At that time cells were extracted and Stat3 phosphorylation levels analysed in the same manner (Xu and Zhao, 2001) . In all cases, very similar results were obtained, indicating that it is the extent of cell-to-cell contact, regardless of time in culture beyond 24 h, that is responsible for the increase in Stat3-ptyr705 levels.
To examine whether this increase in phosphorylation was accompanied by an increase in Stat3 DNA binding activity, nuclear extracts of cells grown to different densities were probed with the hSIE oligonucleotide in electrophoretic mobility shift assays (EMSAs; see Materials and methods). As shown in Figure 1E , the DNA binding values obtained paralleled the increase in Stat3 phosphorylation. Addition of antibodies to total Stat3 or Stat1 in supershift experiments indicated that the bands obtained consist of complexes specifically of Stat3, since the anti-Stat1 antibody did not cause a retardation of the hSIE-containing complexes (lanes 13 and 14; Wagner et al., 1990) . The above results taken together indicate that cell density causes an increase in Stat3 activity in cultured human breast carcinoma cells.
Previous results have shown that one of the nuclear targets of active Stat3 is the Stat3 promoter itself (Narimatsu et al., 2001) . Examination of the levels of total Stat3 protein showed a distinct increase with cell density ( Figure 1A -D, middle panels), although the differences were not as pronounced as the Stat3-705 phosphorylation observed ( Figure 1A -D, top panels).
Cell density modulates Stat3 activity in normal breast epithelial and mouse fibroblast lines
The breast tumor lines examined above are known to possess constitutively activated epidermal growth factor Stat3 and confluence A Vultur et al receptor (EGF-R) and Src kinases. To differentiate the density-induced Stat3 activation mechanism in breast cells, from activation triggered by these oncogenes, we examined Stat3 phosphorylation levels in the normal human breast epithelial MCF-10A line. Cells were plated in Petri dishes and over several days cell extracts Figure 1 Cell density upregulates Stat3 activity in human breast carcinoma lines. Lysates from MDA-MB-453 (A), MDA-MB-231 (B), MDA-MB-468 (C) or MDA-MB-435 (D) human breast carcinoma lines grown to different degrees of confluence and up to 3 days postconfluence as shown were resolved by gel electrophoresis. Western immunoblots were probed for the tyr705 phosphorylated form of Stat3 (top panels), for total Stat3 (middle panels) or Hsp90 (bottom panels), as indicated. In all cases, 50 mg of the lysate were loaded. Numbers at the left refer to molecular weight markers. (E) Autoradiogram of Stat3-hSIE complexes in nuclear extracts from cells prepared at the indicated cell densities. In lanes 13 and 14, the same preparation as in lane 12 was incubated with the anti-Stat1 or anti-Stat3 antibodies, respectively. The arrow points to the position of the complex Stat3:hSIE. The position of the supershifted Stat3-hSIE-antibody complex is indicated with an asterisk
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A Vultur et al were probed with the Stat3-ptyr705 antibody as described above. As shown in Figure 2A (lanes 8-12), there was a dramatic increase in Stat3-tyr705 phosphorylation with cell density, which peaked at 2 days postconfluence (lane 11). The levels obtained at that time were approximately 60% the levels observed in the breast carcinoma line MDA-MB-468 (lane 13) despite the fact that the MCF-10A cells were grown in a medium containing EGF and insulin (see Materials and methods), which would increase Stat3 activity. As shown for the breast carcinoma lines above, plating different numbers of cells so that they reach the same densities within 24 h yielded similar results. These data indicate that, same as in the breast cancer lines, it is the extent of cell-to-cell contact, independent of time in culture, that is responsible for the increase in Stat3-ptyr705 levels in normal breast cells. Although phenotypically normal, MCF-10A cells still require EGF and insulin for growth. We further investigated the density-induced Stat3 activation mechanism, independently from EGF and insulin stimulation, using mouse NIH 3T3 and 10T 1 2 fibroblasts, which grow without supplementation with these growth factors and where Stat3 signalling has been extensively examined (Turkson et al., 1998; Garcia et al., 2001) . Cells were plated in Petri dishes and Stat3-ptyr705 levels were examined at different densities ( Figure 2G ). As shown in Figure 2A (lanes 1-6), contrary to MCF-10A, Stat3-705 levels were almost undetectable in sparse NIH3T3 (lane 1) and increased with cell density to approximately the same degree as the MCF-10A cells. The phosphorylation levels of Stat3, ser727 obtained by probing extracts prepared in a similar manner with an antibody specific for this site, paralleled the levels of Stat3-ptyr705 ( Figure 2D ). Furthermore, same as in the case of breast carcinoma lines, examination of the levels of total Stat3 protein in NIH3T3 cells showed a distinct increase with cell density (Figure 2B ), although the differences were not as pronounced as the Stat3-705 phosphorylation observed (Figure 2A ).
To examine whether this increase in phosphorylation is accompanied by an increase in Stat3 activity, we measured Stat3 DNA binding ability to the hSIE probe in nuclear extracts of NIH 3T3 cells grown to different densities using EMSAs as above. As shown in Figure 2E , the Stat3 DNA binding values paralleled the increase in Stat3 phosphorylation observed. Supershift experiments indicated that the bands obtained consist of complexes of Stat3 specifically (lanes 8-10). Furthermore, examination of Stat3 transcriptional activity in NIH3T3 cells stably expressing a luciferase gene construct under the control of a Stat3-specific promoter (pLucTKS3 plasmid; see Materials and methods) revealed a similar pattern ( Figure 2F ). On the other hand, Stat3-independent transcription from the c-fos, serum response element (SRE) promoter was not affected by cell density, indicating that cell density induces a Stat3 activity increase specifically. Similar results were obtained with mouse 10T 6 per 3 cm dish, respectively) were plated as above and, following overnight attachment in a medium with 10% calf serum, the medium was replaced with serum-free Dulbecco's modified Eagle's medium (DMEM). Following a 24 h serum starvation, proteins were extracted and Stat3 phosphorylation measured as above. As a control, parallel cultures were left in medium with 10% calf serum. Duplicate cultures were treated with EGF for 10 min prior to extraction, in the presence or absence of serum. As shown in Figure 3A , Stat3 phosphorylation did increase with density in serumstarved cells (lanes 1-3), although it peaked to approximately 20% the levels obtained in cells continuously grown in 10% calf serum (lanes 4-8). On the other hand, EGF treatment brought about only a slight increase in Stat3 tyrosine-705 phosphorylation in this system (lanes 1-3 vs 14-16 and 4-8 vs 9-13), at all densities examined and regardless of serum addition. Taken together, these results indicate that the density-mediated increase in Stat3-ptyr705 is substantially greater than the increase brought about by EGF in this system.
Aside from Stat1 and Stat3, a number of growth factors are known to activate the Ras/Raf/Erk pathway. To examine the specificity of the density-induced Stat3 activation observed, we assessed the effect of density upon Erk1/2 activity levels by probing the same extracts as above with an antibody specific for the dually phosphorylated, that is activated, form of the Erk1/2 kinase. In agreement with previous results (Raptis et al., 2000) , serum addition did increase Erk1/2 phosphorylation levels ( Figure 3B , lanes 1-3 vs 4-8). However, in sharp contrast to Stat3, cell density had no detectable effect upon Erk1/2 activity levels, regardless of serum addition ( Figure 3B , lanes 1-3 and 4-8). On the other hand, EGF treatment caused a dramatic increase in Erk1/2 activity, either in the presence (lanes 4-8 vs 9-13) or absence (lanes 1-3 vs 14-16) of serum. As expected, when a fixed number of cells were plated and harvested at different densities without changing the medium for the duration of the experiment, Erk1/2 activity levels gradually declined to background, regardless of cell density (not shown). This is in stark contrast to the pattern observed for Stat3 phosphorylation as a function of confluence, and indicates that the two pathways are not coordinately regulated; while Erk1/2 activity is exquisitely sensitive to growth factor Stat3 and confluence A Vultur et al stimulation in this system, unlike Stat3, it is not affected by cell density. In all of the above experiments, Stat3 DNA binding as well as transcriptional activity followed the Stat3 phosphorylation levels (not shown).
Aside from activated EGFR, the breast carcinoma lines also express activated Src, a potent Stat3 stimulator (Garcia et al., 1997) . To investigate the possible collaboration between activated Src and cell density, we examined Stat3 phosphorylation levels in v-Src-expressing NIH 3T3 cells grown to different densities in 10% calf serum as above. As shown in Figure 3C (top panel), although v-Src-transformed cells displayed elevated Stat3-ptyr705 levels compared to the parental NIH 3T3 when sparse, these levels did increase approximately fourfold at postconfluence. As expected, examination of Stat3 transcriptional activity in cells stably expressing vSrc and the firefly luciferase gene under control of the Stat3-specific promoter (pLucTKS3; see Materials and methods) revealed a similar pattern. As a control, Stat3-independent transcription from the c-fos, SRE promoter was not affected by cell density ( Figure 3D ). These results indicate that, in a manner similar to the tumor lines, although v-Src activates Stat3, cell density can activate it even further in an additive way.
Cell-to-cell contact mediates the Stat3 activity increase
The interaction of a cell with its environment consists of cell-to-matrix and cell-to-cell adhesions. A cell senses these environmental signals through integrinand cadherin-based adhesion molecules, respectively (Juliano, 2002) . To examine whether the observed increase in Stat3 phosphorylation with cell density is due to cell adhesion as opposed to the growth arrest brought about by confluence, both cell-to-cell and cellto-substrate interactions were disrupted through treatment with divalent cation chelators (see Materials and methods). Mouse NIH3T3 fibroblasts were grown to different densities as above and treated with the EGTA/ EDTA, calcium-chelating solution for 15, 30 or 60 min, followed by examination of Stat3-ptyr705 levels or Stat3 DNA binding activity in cell extracts.
Postconfluent cells required 30-60 min for dissociation, although 15 min were sufficient for cells at 60% confluence ( Figure 4C ,b). Replating them in complete medium indicated that in all cases cells were viable even after a 60 min treatment. As shown in Figure 4A , the EGTA/EDTA treatment caused a dramatic decrease in Stat3 phosphorylation to background levels within 60 min at all densities examined. As expected, the reduction was achieved faster in the cells at 60% confluence, when Stat3-ptyr705 levels were lowest (lanes 1-4 vs 13-16). Blotting against total Stat3 protein revealed no reduction ( Figure 4A , middle panel), indicating that it may be the inhibition of Stat3-tyr705 phosphorylation, rather than Stat3 protein degradation which is responsible for the observed reduction in Stat3-ptyr705 levels. EMSA analysis indicated that the Stat3 DNA binding activity closely paralleled the Stat3-ptyr705 levels ( Figure 4B , lanes 1 and 3 vs 2 and 4). Similar results were obtained with MCF-10A cells and with pLucTKS3-transfected NIH3T3 cells. In the latter, to examine the decline in Stat3 transcriptional activity with cell dissociation, cells were treated with EGTA/ EDTA for 10 min followed by a 24 or 48 h incubation in calcium-free DMEM to allow for decay of the preexisting luciferase activity. As shown in Figure 4D , the luciferase levels measured were dramatically reduced by calcium chelation within 24 h, indicating that calcium chelation, aside from a reduction in Stat3 phosphorylation, leads to a reduction in Stat3 transcriptional activity as well. At the same time, transcription from the Stat3-independent c-fos SRE promoter element was unaffected ( Figure 4D ), while replating the cells in calcium-containing medium led to an increase in luciferase activity, indicating the lack of overt toxicity due to the EGTA/EDTA treatment.
To further confirm that acquired cell-to-cell contact can lead to Stat3-tyr705 phosphorylation, sparsely growing NIH 3T3 cells were separated into a singlecell suspension by EGTA/EDTA treatment and dispersed by vigorous pipetting. Suspended cells were subsequently allowed to aggregate following plating at a high density (5 Â 10 6 cells/ml) in agar-coated, 6 cm plates for 16 h ( Figure 4C,c) . Under these conditions, cells remained rounded and detached, indicating that cell-matrix adhesion in the agar-coated plates most likely did not occur. As shown in Figure 4E , cell aggregation resulted in a dramatic increase in Stat3-ptyr705 levels and Stat3 DNA binding ability, indicating that it is cell-to-cell rather than cell-matrix adhesion which is required for this effect. Similarly, postconfluent Figure 2 Stat3 phosphorylation and activity during normal cell proliferation, confluence and postconfluence. Lysates from normal mouse NIH 3T3 fibroblasts (lanes 1-6) or normal human breast epithelial MCF-10A cells (lanes 8-12) grown to different degrees of confluence and up to 4 days postconfluence as indicated were resolved by gel electrophoresis. Western immunoblots were probed for (A) the tyr705 phosphorylated form of Stat3, (B) total Stat3 protein, (C) Hsp90, (D) the ser727 phosphorylated form of Stat3, as indicated. In all cases, 50 mg of lysate were loaded. Numbers at the left refer to molecular weight markers. Lane 7: NIH 3T3 cells transformed by v-Src. Lane 13: MDA-MB-468 breast carcinoma cells. (E) Autoradiogram of Stat3-hSIE complexes in nuclear extracts from cells prepared at the indicated cell densities. The arrow points to the position of the complex Stat3:hSIE. In lanes 9 and 10, the same sample as in lane 8 was incubated with the anti-Stat1 or anti-Stat3 antibodies, respectively. The position of the supershifted Stat3-hSIE-antibody complex is indicated with an asterisk. (F) Stat3 transcriptional activity as a function of cell density. NIH 3T3 cells stably expressing the Stat3-dependent pLucTKS3 reporter driving a firefly luciferase gene under control of the hSIE promoter element, and the Stat3-independent pRLSRE reporter driving a Renilla luciferase gene under control of the c-fos SRE promoter, respectively, were grown to the indicated densities with daily media changes, and firefly (') or Renilla (&) luciferase activities were determined in cytosolic extracts (see Materials and methods). Values shown represent luciferase units expressed as % of the highest value obtained, means plus standard deviations of at least three experiments, each performed in triplicate. (G) NIH 3T3 cells grown to the indicated densities were photographed under phase-contrast illumination. Bar represents 100 mm cells that were detached from the plastic plate with a rubber policeman maintained high Stat3 activity after plating on agar-coated dishes for 1-24 h (not shown). Taken together, the above results indicate that cell-tocell contact mediates the Stat3 activity increase in normal as well as v-Src-transformed fibroblasts. Furthermore, since high levels of Stat3-ptyr705 phosphorylation were present in the absence of cell attachment and spreading on ECM, it appears that integrin-based adhesion interactions are unlikely to be involved.
Sensitivity to Src inhibition -distinct pathways of Stat3 activation in tumor lines
The above results reveal that cell-cell adhesion triggers a dramatic increase in Stat3 activity in normal breast epithelial cells or mouse fibroblasts. In an attempt to examine the mechanism of this activation, we explored the potential role of a number of tyrosine kinases known to be involved in cell adhesion signalling, as well as to activate Stat3. Stat3 phosphorylation by cytokine receptors such as IL6, which lack intrinsic tyrosine kinase activity, is mediated by the associated JAKs. On the other hand, STAT activation following stimulation of tyrosine kinase receptors is a complex process; both Stat1 and Stat3 are activated by EGFR or PDGFR, and this requires both the JAK and Src kinases (Vignais et al., 1996; Cirri et al., 1997; Olayioye et al., 1999; Vignais and Gilman, 1999; Wang et al., 2000) .
MDA-MB-468, MDA-MB-231 and MDA-MB-435 breast carcinoma cells were previously shown to have increased Src activity levels (Garcia et al., 1997) , a kinase known to also play a role in cell adhesion signalling (Juliano, 2002) . To examine the role of the Src kinase upon Stat3-tyr705 phosphorylation in these lines, cells were grown to different densities and treated with the Src-selective inhibitor PD180970 for 24 h prior to lysis and examination of Stat3-ptyr 705 levels. As shown before (Garcia et al., 2001) , a 24 h PD180970 treatment dramatically reduced Stat3-tyr705 phosphorylation in 70% confluent MDA-MB-468 cells ( Figure 5A , top panel, lane 5 vs 6). However, PD180970 reduced Stat3-ptyr705 levels by B20% only in these cells at the peak of 1 day postconfluence ( Figure 5 , lanes 2 vs 3 and Table 1 ). To confirm the PD180970 resistance of the confluencemediated Stat3 activity increase, cells were continuously grown to different densities, in the presence or absence of the drug. While cell growth was slowed by the drug due to the prolonged treatment (up to 7 days), Stat3-ptyr705 levels were not reduced by more than B25% that of confluent cells. Similarly, although a 48 h PD180970 treatment dramatically reduced luciferase levels in subconfluent, pLucTKS3-transfected, v-Srctransformed NIH3T3 cells, it only reduced Stat3 activity by B20% in the same cells at postconfluence ( Figure 5B ). This difference in PD180970 sensitivity cannot be attributed to the lower Stat3 levels in subconfluent cells, since PD180970 treatment did not substantially reduce Stat3 activity at later stages, when Stat3 levels had declined, possibly due to impending cell death (Table 1) . These unexpected findings hinted at the possibility that the density-induced Stat3 activation may be Src independent. This conclusion was reinforced by the observation that PD180970 treatment of normal NIH 3T3 cells did not reduce the density-induced increase of Stat3-ptyr705 (Table 1) . These results reveal that there may be two distinct pathways for Stat3 activation in the tumor cells, based on their sensitivity to Src inhibition: the constitutive, Src-activated pool that is inhibited by PD180970 and the density-induced one which is apparently Src-independent. To further evaluate this possibility, we analysed Stat3-ptyr705 levels in normal fibroblasts established from knockout mice, where the c-Src as well as the related c-Yes and c-Fyn kinases had been ablated (SYFÀ/À cells; Klinghoffer et al., 1999) . Cells were grown to different densities and Stat3-ptyr705 levels were examined as above. As shown in Figure 5C (top panel, lanes 1-8), Stat3-ptyr705 levels in SYFÀ/À cells were indistinguishable from the levels in SYFÀ/À cells where the c-src gene had been added back (SYF-Src cells, lanes 9-15), or their wild-type (wt) counterparts. As expected, given the slower growth rate of SYFÀ/À cells, the timeframe of Stat3-ptyr705 increase in the SYFÀ/À cells was delayed, peaking at 3-4 days postconfluence, as opposed to 1-2 days in wt cells. These results taken together indicate that Src family kinases play no significant role in the density-dependent Stat3 activation in either normal or tumor cells.
Since cell-to-cell adhesion activates Stat3 in normal cells, we next examined the possible role of kinases of the Fps/Fes and Fer family. These are members of a distinct subfamily of the nonreceptor protein-tyrosine kinases, which were recently found to play a role in regulating cytoskeletal rearrangements and inside-out signalling that accompany receptor-ligand, cell-ECM and cell-tocell interactions (Greer, 2002) . To examine whether the Fer kinase might be involved in the density-mediated Stat3 activation, primary embryo or established fibroblasts derived from knockout mice, where this gene had Stat3 and confluence A Vultur et al been genetically ablated, were grown to confluence, and at different times thereafter, Stat3-ptyr705 levels examined as above. As shown in Figure 5D , Stat3-ptyr705 levels in the FerÀ/À cells were indistinguishable from the levels in their wt littermates (lanes 1-5 vs 6-10), indicating that the Fer kinase plays no significant role in the density-dependent Stat3 activation.
Another receptor tyrosine kinase previously shown to play a role in regulating cell-to-cell adhesion is the insulin-like growth factor-1 receptor (IGF1R) (Mauro et al., 2003) . However, similar to the Fer kinase, examination of Stat3-ptyr705 levels in cells from IGF1R À/À mice (Sell et al., 1994) revealed that Stat3 activity levels did increase with confluence, to a peak indistinguishable from their wt littermates. These results indicate that, same as the Fer kinase, this receptor does not play a significant role in the density-mediated Stat3 activation ( Figure 5E , lanes 1-5 vs 6-10). Similarly, as shown before for squamous cell carcinoma cells of the head and neck (SCCHN; Steinman et al., 2003) , the EGF receptor-selective inhibitor PD158780 did not reduce the density-mediated Stat3-tyr705 phosphorylation in NIH3T3 fibroblasts (Table 1) .
Recent results have revealed extensive interactions between cell-to-cell adhesion molecules such as cadherins with other adhesion receptors, notably integrins (Huttenlocher et al., 1998; Whittard et al., 2002) . Integrin signalling, in turn, has been shown to activate the Ras pathway through a number of intermediates such as the focal adhesion kinase (FAK; Juliano, 2002) . To explore whether the Ras pathway might be involved in the density-mediated Stat3 activation, Stat3-ptyr705 phosphorylation was examined in c-Ras-deficient 10T 1 2 fibroblasts (line 25B8; Raptis et al., 1997a) , as a function of confluence as above. Due to the introduction of a rasantisense construct, these cells express approximately 30% the levels of the parental 10T 1 2 and as a result display a very slow growth and flat morphology (Raptis et al., 1997a) . As shown in Figure 5F , Stat3-ptyr705 phosphorylation levels did increase with density in 25B8 cells (lanes 1-5) and to the same levels as in the parental 10T 1 2 (lanes 6-10), indicating that the Ras pathway does not play a significant role in the density-dependent Stat3 activation. Just as in the case of SYFÀ/À cells, the increase in Stat3-ptyr705 is delayed in FerÀ/À, as well as IGF1RÀ/À and Ras-deficient cells, possibly due to their slower growth rate.
JAK mediates the confluence-induced Stat3 activation
We previously demonstrated that the JAK-specific inhibitor AG490 could inhibit Stat3 activity in subconfluent, breast tumor lines (Garcia et al., 2001) . To examine the involvement of the JAK kinases in the density-mediated Stat3-tyr705 phosphorylation, NIH 3T3 cells were grown to different densities in the presence or absence of the JAK-specific inhibitor AG490, and Stat3-ptyr705 levels were examined as above. In agreement with previous results (Zhang et al., 2000) , AG490 treatment abolished Stat3-tyr705 phosphorylation in sparse v-Src-transformed NIH3T3 cells ( Figure 6A , lane 11 vs 12). Contrary to PD180970 however, AG490 reduced Stat3-ptyr705 levels in normal NIH3T3 cells to approximately 40% the levels in the controls treated with the DMSO carrier alone ( Figure 6A ). These results indicate that, although JAK kinases are required, other kinases may partially substitute for JAK under conditions of JAK inhibition in confluent cells. As expected, Stat3 DNA binding activity paralleled the Stat3 phosphorylation levels ( Figure 6B ). Similar results were obtained with the normal breast MCF-10A cells, while the reduction in the breast carcinoma MDA-MB-468, MDA-MB-435 and MDA-MB-231 lines was similar to the v-Src-transformed cells ( Figure 5A , lanes 4 and 7 and Table 1 ). In all cases, similar results were obtained when cells were treated with the inhibitor for only 24 h prior to lysis (Table 1) .
A corollary to the concept that the JAK kinases may mediate Stat3 activation in confluent cells is that cell density must increase JAK activity. To this effect, Janus kinase-1 (Jak1) in vitro kinase activity levels were examined in NIH 3T3 cells grown to different densities as above. As shown in Figure 6C , there was a dramatic increase in Jak1 kinase activity with cell density, further reinforcing the conclusion that Jak1 is at least in part mediating Stat3 phosphorylation in this system. Total Jak1 protein levels were not affected (lanes 7-8). These results taken together indicate that the Jak1 kinase is, in fact, involved in this process, although it may not be solely responsible for Stat3 phosphorylation in confluent cells.
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Stat3 inhibition at confluence promotes apoptosis
Previous results have shown that Stat3 signalling contributes to the induction of the antiapoptotic bclxL and mcl-1 genes, thus protecting tumor cells from apoptosis (Bromberg et al., 1999; Catlett-Falcone et al., 1999b; Grandis et al., 2000; Bowman et al., 2001; Epling-Burnette et al., 2001) . To examine the functional consequences of the confluence-mediated Stat3 activation, normal or v-Src-transformed NIH 3T3 cells were treated at confluence with a peptide previously demonstrated to block the Stat3-SH2 domain and inhibit Stat3 activity in vivo when introduced into cultured cells through a membrane-translocation sequence (PY*LKTK-mts; Turkson et al., 2001) . Following treatment, cells were fixed and apoptotic death assessed by in situ TUNEL staining as well as by fluorescenceactivated cell sorter (FACS) analysis of the cellular sub-G1 profile (Lin et al., 2002) . As a control, we used the same sequence containing tyrosine instead of phosphotyrosine (see Materials and methods).
In agreement with previous findings , Stat3 inhibition even in subconfluent, v-Srctransformed NIH3T3 cells induced apoptosis, although apoptosis induction was greater in confluent cells (Figure 7 ). On the other hand, treatment of subconfluent, normal NIH 3T3 cells with this peptide had no significant effect. However, treatment of NIH 3T3 cells for 30-48 h at 1-3 days postconfluence caused a dramatic increase in apoptotic death (Figure 7) . At the same time, the control peptide containing nonphosphorylated tyrosine had no significant effect. These results indicate that inhibition of Stat3 signalling in postconfluent NIH3T3 cells induces DNA degradation and apoptosis.
Discussion
Results from several laboratories have indicated that Stat3 is constitutively activated in cell lines transformed by diverse oncoproteins, as well as in many human cancers (Garcia et al., 2001; Mora et al., 2002) . In addition, a constitutively active Stat3 mutant alone is sufficient to induce cell transformation and tumor formation in nude mice (Bromberg et al., 1999) , providing genetic evidence for the growth-promoting potential of Stat3. Given this association of Stat3 with cell proliferation, we predicted that cell growth arrest through confluence might suppress Stat3 activity. 1-4) . Lanes 9-10: 60% confluent, v-Src-expressing NIH 3T3 cells treated with AG490 (lane 10) or the DMSO diluent (lane 9). (C) Jak1 kinase activity increases with cell density. Jak1 was immunoprecipitated from NIH 3T3 cells grown to different densities prior to the addition of 50 mCi [g 32 P]ATP, electrophoresis and autoradiography (Zhang et al., 2000) . Lanes 7 and 8: As a control, Jak1 immunoprecipitates were blotted and probed with the same anti-Jak1 antibody
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A Vultur et al the Ras/Raf/Erk pathway, known to be activated by a large array of receptor or nonreceptor tyrosine kinases. The latter was found to be activated only in response to serum or EGF addition, regardless of cell density, indicating that cell density regulates Stat3 activity independent of the Ras pathway. This increase is not simply a secondary consequence of the confluenceinduced growth inhibition, since growth arrest of sparsely grown cells by serum starvation did not increase Stat3-ptyr705 levels. The observed increase in Stat3-ptyr705 phosphorylation, in turn, resulted in an increase in Stat3 DNA binding and transcriptional activity. These results are in agreement with a recent report (Steinman et al., 2003) , indicating Stat3 upregulation with density in SCCHN cells. Contrary to these lines however, following the increase, we saw a decline in Stat3 activity at later times postconfluence, in all lines examined. Our results further reveal a potent Stat3 stimulation even in normal breast epithelial or mouse fibroblast lines, which is refractory to inhibition of a number of kinases known to play a role in cell adhesion signalling. These observations raise important questions: Stimulation of a large number of receptors, such as growth factor receptors with tyrosine kinase activity like EGF, PDGF or HGF, as well as cytokine receptors lacking intrinsic tyrosine kinase activity (e.g. IL6) is known to result in phosphorylation and activation of Stat3, mediated by the receptor itself and/or JAKs or Src (Levy and Darnell, 2002) . Our results reveal that in the tumor lines possessing activated Src, there might be two distinct mechanisms of Stat3 activation, based on their sensitivity to Src inhibition: constitutive Stat3 activation that is dependent upon Src activity, and the Src-independent density-induced activation; while PD180970 inhibited the constitutive Stat3 in these tumor lines, it did not affect the density-induced Stat3 activation in the same cells. Similarly, PD180970 did not inhibit the density-dependent Stat3 activation in normal cells, which is consistent with the lack of effect of genetic ablation of the c-src as well as the related c-fyn and c-yes genes on Stat3 activity at postconfluence. Thus, these kinases are not required for the density-induced Stat3 phosphorylation. Moreover, receptor tyrosine kinases of the Fer and IGF1R families that are known to play a role in cell adhesion signalling may play no role in the density-induced Stat3 phosphorylation, since genetic ablation of these kinases did not affect Stat3 levels. Our results are also in agreement with a recent report showing a lack of effect of EGFR upon the densityinduced Stat3 activation (Steinman et al., 2003) . However, the possibility that these kinases might substitute for one another once one of them is blocked cannot be excluded. On the other hand, our results reveal that inhibition of the JAK kinases in confluent NIH 3T3 cells reduces Stat3 phosphorylation, indicating that JAKs are indeed required for the density-induced Stat3 phosphorylation and activation.
Disruption of cell-to-cell contacts in confluent cells by calcium chelation reduced Stat3 activity levels indicating that phosphorylation of Stat3-tyr705 may be induced by signalling through cell-to-cell adhesion. Possible upstream inducers of this pathway known to cause cell growth inhibition through cell-to-cell adhesion include molecules such as cadherins. Cadherin engagement is known to lead to growth inhibition by competing with the Wnt signalling pathway for b-catenin binding (Juliano, 2002) . Cadherin engagement also activates other signalling molecules, including the phosphatidylinositol-3 kinase (PI3k; Pece et al., 1999; Kovacs et al., 2002) and the GTPase Rac1 (Faruqi et al., 2001; Noren et al., 2001; Goodwin et al., 2003; reviewed in Yap and Kovacs, 2003) . Although PI3k/Rac activation has not been examined in our system, it is interesting to note that they were previously found to be highly activated at more than 48 h postconfluence, at which time cell-cell contacts are highest, while the influence of integrin-ECM interactions is minimized (Pece et al., 1999) . In addition, more recent studies demonstrated that Rac1 can mediate Stat3 phosphorylation (on both tyrosine and serine residues; Simon et al., 2000) , and activation in a JAK-dependent manner, which occurs consequent to a transcriptional induction of the IL6 gene and its receptor, acting in an autocrine manner (Simon et al., 2000; Faruqi et al., 2001) . The PI3k/Akt as well as the observed Stat3 activation brought about by cell-cell contact might, in turn, aid the cell in avoiding apoptosis (Pece et al., 1999) . These scenarios are currently being investigated. On the other hand, while we do not have evidence to exclude the possibility that the FAK might phosphorylate Stat3 through E-cadherin/a2b1 integrin signalling (Whittard et al., 2002) , the absence of Erk1/2 activation in our system, which would normally be activated by integrin signalling (Juliano, 2002) , together with the observation that the density-dependent Stat3 activation did occur in the face of Ras downregulation, tends to argue against this interpretation. An additional possibility is that phosphatases such as TC-PTP, which can serve as negative regulators of Stat3 as well as Stat5a and Stat5b (Yamamoto et al., 2002) , may become inactivated in confluent cells, thereby promoting Stat3 phosphorylation and activity. These mechanisms are presently under study.
Although Stat3 may play a causal role in human tumor formation, and in a constitutively active form can transform cultured cells, it is also activated in growtharrested keratinocytes (Hauser et al., 1998; Bowman et al., 2000) or adipocytes (Stephens et al., 1996; Balhoff and Stephens, 1998; Deng et al., 2000) . Stat3 has been shown to induce transcription of a number of genes, including myc, bcl-x, the hepatocyte growth factor receptor (Hung and Elliott, 2001) , cyclin D1 and E, as well as the cyclin-dependent kinase inhibitor, p21 cip/waf (Sinibaldi et al., 2000) , which play important roles in cell proliferation and survival (Battle and Frank, 2002) . How the induction of these cell cycle regulators is modified in response to Stat3 activation in confluent cells is currently under investigation. Our observation that Stat3 inhibition at postconfluence of normal cells promotes apoptosis points to the possibility that the increased Stat3 activity may reflect a protective, survival mechanism that is engaged as cells reach confluence. Indeed this increase, which peaks after confluence when cells are growth arrested and entering apoptosis, may represent a futile attempt by the cell to overcome apoptotic death. The fact that Stat3 inhibition at confluence promotes apoptosis supports this interpretation. Although the physiological role of elevated Stat3 activity during confluence remains to be fully determined, it is clear that confluence-induced effects upon Stat3 activity must be taken into account in studies of Stat3 signalling induced by growth factors, oncogenes or neoplasia. Our data show that the total level of Stat3 signalling at any given time in a cell would be the cumulative effect of both the confluence state and the Stat3-activating factors under study.
Materials and methods
Cell lines and culture techniques
Tissue culture medium (Dulbecco's modification of Eagle's medium, DMEM) was from ICN (Aurora, OH) and calf serum from Life Technologies Inc. (Burlington, Ontario). Normal mouse NIH 3T3, and NIH 3T3 transformed by v-Src (Zhang et al., 2000) , mouse 10T 1 2 and rat F111 fibroblasts have been described previously (Raptis et al., 1997b) and were grown in plastic dishes in DMEM supplemented with 10% calf serum, in a 7% CO 2 incubator. Breast carcinoma lines MDA-MB-453, MDA-MB-468, MDA-MB-231 and MDA-MB-435 (Garcia et al., 2001) were grown in DMEM supplemented with 10% fetal calf serum. MCF-10A cells were maintained in DMEM:F12 medium supplemented with 5% fetal calf serum, 10 mg/ml insulin, 500 ng/ml hydrocortisone, 20 ng/ml EGF and 100 ng/ml cholera toxin (Garcia et al., 1997) .
For treatment with the AG490 JAK inhibitor, cells were incubated with 50 mM AG490 for a total of 1-8 days, with redosing every 12 h as described (Zhang et al., 2000) . Treatment with the PD180970 Src inhibitor was at a final concentration of 1 mM with redosing every 12 h for a total of 1-7 days as indicated. Alternatively, cells were treated with the inhibitors for 24 or 48 h at all time points prior to lysis, as described in the text. All inhibitor stock solutions were prepared in DMSO and subsequently added to serum-containing medium to obtain the final concentrations designated. For cell dissociation, cells were treated with EGTA/EDTA buffer (0.5 mM EGTA, 0.5 mM EDTA in PBS) (Rothen-Rutishauser et al., 2002) for the indicated times (15-60 min) and extracted immediately for Stat3-ptyr705 determination. In all cases, cell viability was assessed by trypan blue exclusion and by replating the cells in medium lacking the inhibitors, or without EGTA/EDTA and containing calcium, respectively. For measurement of the reduction in Stat3 transcriptional activity following a 10 min EGTA/EDTA treatment, pLucTKS3-transfected cells were incubated in calcium-free DMEM (Life Technologies) for 24 or 48 h prior to lysis, to allow for decay of the pre-existing luciferase activity.
For cell aggregation assays, subconfluent cells were dissociated with EGTA/EDTA treatment, then allowed to aggregate spontaneously by plating 5 Â 10 6 cells on an agarcoated, 6 cm plate for a number of hours, as indicated. For EGF treatment, the medium was changed to DMEM supplemented with 100 ng/ml EGF (Intergen). Cell confluence was estimated visually and quantitated by imaging analysis of live cells under phase contrast using a Leitz Diaplan microscope and the MCID-elite software (Imaging Research, St Catharine's Ont.).
For downregulation of Stat3 activity, cells were treated with 1 mM of a peptide that binds to and blocks the Stat3-SH2 domain (PY*LKTK-mts, Y*, phosphotyrosine, mts, membrane translocation sequence, AAVLLPVLLAAP), for 48 h. As a control, cells were treated with the same peptide containing tyrosine instead of phosphotyrosine. Our previous results indicated that this treatment dramatically reduces Stat3 activity . Apoptosis was assessed through TUNEL staining using FITC-coupled nucleotides, according to the manufacturer's instructions (Roche, #1684809), and cells with apoptotic nuclei were visualized under fluorescence and phase-contrast illumination. For a more precise quantitation, cells growing in a 6 cm plate were fixed with ethanol, stained with propidium iodide and the percentage of cells with a sub-G1 DNA content was assessed by FACS analysis (Lin et al., 2002) .
Western blotting and in vitro kinase assays
Cells were grown to different densities and proteins were extracted using 50 mM Hepes, pH 7.4, 150 mM NaCl, 10 mM EDTA, 10 mM Na 4 P 2 O 7 , 100 mM NaF, 2 mM Na 3 VO 4 , 0.5 mM PMSF, 10 mg/ml aprotinin, 10 mg/ml leupeptin and 1% Triton X-100 (Raptis et al., 2000) . In each assay, 50 mg of clarified cell extract were resolved on a 10% polyacrylamide-SDS gel and transferred to a nitrocellulose membrane (Bio-Rad). The membranes were blocked with 5% nonfat milk for at least 1 h followed by an overnight incubation in primary antibody.
Immunodetection was performed using antibodies against the tyrosine-705 phosphorylated (i.e. activated) form of Stat3 (Biosource International), against total Stat3 (Cell Signalling, cat.# 9132) or against the serine-727 phosphorylated form of Stat3 (Biosource International), followed by alkaline phosphatase-conjugated goat secondary antibodies (Biosource). The bands were visualized using enhanced chemiluminescence (ECL), according to the manufacturer's instructions (PerkinElmer Life Sciences, cat.# NEL602). In parallel experiments, blots were probed with an antibody to the dually phosphorylated, that is activated, form of Erk1/2 (Biosource). As a control for protein loading, parallel blots were routinely probed with the mouse monoclonal anti-Hsp90 antibody (Stressgen, cat.# SPA-830), followed by a secondary antibody and ECL detection as above. For Jak1 in vitro kinase assays, extracts were precipitated with the HR785 antibody to Jak1 (Santa-Cruz) and 50 ml packed Staph. A-sepharose beads (Pharmacia). Following addition of 50 mCi [g 32 P]ATP to washed immunoprecipitates, eluted proteins were resolved by polyacrylamide gel electrophoresis and autoradiography as previously described (Zhang et al., 2000) . Quantitation was achieved by phosphorimager analysis using a Molecular Dynamics Storm phosphorimager and the ImageQuant program, or by fluorimager analysis using the FluorChem program (AlphaInnotech Corp).
Electrophoretic mobility shift assays
The procedures for nuclear extract preparation from NIH3T3 fibroblasts or their v-Src-transformed counterparts and EMSAs were essentially as previously described (Yu et al., 1995) . The 32 P-labelled oligonucleotide probe used was the hSIE (high-affinity sis-inducible element, m67 variant, 5 0 -AGCTTCATTTCCCGTAAATCCCTA) that binds both Stat1 and Stat3 (Wagner et al., 1990) . For supershift assays, 1 mg of the anti-Stat3 antibody was preincubated with the nuclear cell extract for 30 min prior to the addition of the radiolabelled probe (Zhang et al., 2000) . The reactions were incubated at 301C for 30 min and then resolved on nondenaturing, 5% polyacrylamide gels in Tris-borate-EDTA buffer. Stat3-DNA complexes were detected by autoradiography. Quantitation was achieved by phosphorimager analysis.
Luciferase assays for Stat3 transcriptional activity NIH3T3 cells expressing v-Src or not were transfected with a Stat3-specific reporter plasmid (pLucTKS3) that harbors seven copies of a sequence corresponding to the Stat3-specific binding site in the C-reactive gene promoter (termed APRE, TTCCCGAA) upstream from a firefly luciferase coding sequence (Turkson et al., 1998) , with G418 resistance coselection. Individual clones were grown and screened for firefly luciferase activity, measured in total cell extracts according to the manufacturer's protocol (Promega, cat.# E4030). As a control, pLucTKS3-expressing cells were stably transfected with a different reporter, pRLSRE, which contains two copies of the SRE of the c-fos promoter, subcloned into the Renilla luciferase reporter, pRL-null (Promega), and Zeocin resistance coselection . The firefly and Renilla luciferases utilize different substrates and thus can be assayed independently in the same lysates using this kit.
Abbreviations
STATs, signal transducers and activators of transcription; Stat3, signal transducer and activator of transcription-3; JAKs, Janus kinases; Jak1, Janus kinase-1.
